University of California, Los Angeles (UCLA), Health Sciences

Grant boosts psychosocial care resources during COVID-19 pandemic

Newswise — LOS ANGELES — The Simms/Mann-UCLA Center for Integrative Oncology has received a $50,000 grant from Los Angeles-based PHASE ONE Foundation to support psychosocial care for people with cancer, their families and frontline healthcare workers during the COVID-19 pandemic.

The center is providing individual and group support for frontline COVID-19 staff in the hospitals by establishing virtual support groups and other empowering programs to help with the added burdens healthcare workers face during the pandemic.

In addition to supporting the UCLA Simms/Mann Center, the grant also inspired matching support from the community for UCLA Health’s COVID-19 Patient Care and Healthcare Provider Protection Fund.

 “PHASE ONE has supported cancer research for the past two decades, emphasizing funding innovative clinical trials. However, we also realize the importance of providing distinct resources through community grants,” said Edward A. Woods, PHASE ONE Board Member.

“The devastating reality of COVID-19 magnified the importance of supporting hospital programs, and we are thrilled to provide this grant to the Simms/Mann-UCLA Center for Integrative Oncology, particularly during this time of extreme psychological stressors. Our grant will not only provide support for patients and their families, but also for those who have shown unbelievable professional commitment as well as for those who continue to selflessly volunteer to assist those in need.”

 "The PHASE ONE grant greatly enhances the work of the center and extends its care to all those who have been touched by this pandemic – not just our patients with cancer and their loved ones, but also the frontline workers who are stepping in to provide emotional and spiritual support to those in greatest need,” said Kauser Ahmed, PhD, director of the Simms/Mann – UCLA Center for Integrative Oncology. “The grant allows the center to bring this vital and sustaining circle of care to all in our healthcare community.”

Psychosocial treatment at UCLA Simms/Mann Center, which is part of the UCLA Jonsson Comprehensive Cancer Center, UCLA Health and the Division of Hematology/Oncology in the David Geffen School of Medicine, involves a wide range of individual, family and group therapy in addition to psychiatric care. These services include educational programs in nutrition, spiritual care, qi gong and meditation; and workshops such as healing through art and preparing for surgery. The center’s mission is to empower patients and families with support that enhances their overall well-being as they go through the many challenges of a cancer diagnosis.

PHASE ONE is a nonprofit dedicated to supporting ground-breaking Phase I and Phase II clinical cancer research, innovative education and treatment programs, and funding forward-thinking leaders in the scientific and medical community.  PHASE ONE has raised more than 20 million dollars and has supported over 30 ground-breaking cancer clinical trials and treatments over the past 20 years.

 




Filters close

Showing results

110 of 3395
Newswise: Historical Racial & Ethnic Health Inequities Account for Disproportionate COVID-19 Impact
22-Sep-2020 4:00 PM EDT
Historical Racial & Ethnic Health Inequities Account for Disproportionate COVID-19 Impact
American Thoracic Society (ATS)

A new Viewpoint piece published online in the Annals of the American Thoracic Society examines the ways in which COVID-19 disproportionately impacts historically disadvantaged communities of color in the United States, and how baseline inequalities in our health system are amplified by the pandemic. The authors also discuss potential solutions.

Released: 24-Sep-2020 5:05 PM EDT
In-person college instruction leading to thousands of COVID-19 cases per day in US
University of Washington

Reopening university and college campuses with primarily in-person instruction is associated with a significant increase in cases of COVID-19 in the counties where the schools are located.

Newswise: Some Severe COVID-19 Cases Linked to Genetic Mutations or Antibodies that Attack the Body
Released: 24-Sep-2020 3:25 PM EDT
Some Severe COVID-19 Cases Linked to Genetic Mutations or Antibodies that Attack the Body
Howard Hughes Medical Institute (HHMI)

Two new studies offer an explanation for why COVID-19 cases can be so variable. A subset of patients has mutations in key immunity genes; other patients have auto-antibodies that target the same components of the immune system. Both circumstances could contribute to severe forms of the disease.

access_time Embargo lifts in 2 days
Embargo will expire: 25-Sep-2020 6:30 PM EDT Released to reporters: 24-Sep-2020 3:20 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 25-Sep-2020 6:30 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

17-Sep-2020 1:15 PM EDT
Accuracy of commercial antibody kits for SARS-CoV-2 varies widely
PLOS

There is wide variation in the performance of commercial kits for detecting antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), according to a study published September 24 in the open-access journal PLOS Pathogens by Jonathan Edgeworth and Blair Merrick of Guy’s and St Thomas’ NHS Foundation Trust, Suzanne Pickering and Katie Doores of King's College London, and colleagues. As noted by the authors, the rigorous comparison of antibody testing platforms will inform the deployment of point-of-care technologies in healthcare settings and their use in monitoring SARS-CoV-2 infections.

24-Sep-2020 9:25 AM EDT
Loneliness levels high during COVID-19 lockdown
Newswise Review

During the initial phase of COVID-19 lockdown, rates of loneliness among people in the UK were high and were associated with a number of social and health factors, according to a new study published this week in the open-access journal PLOS ONE by Jenny Groarke of Queen’s University Belfast, UK, and colleagues.

Newswise: Genetic, immunological abnormalities in Type I interferon pathway are risk factors for severe COVID-19
24-Sep-2020 12:35 PM EDT
Genetic, immunological abnormalities in Type I interferon pathway are risk factors for severe COVID-19
Uniformed Services University of the Health Sciences (USU)

Individuals with severe forms of COVID-19 disease can present with compromised type I interferon (IFN) responses based on their genetics, according to results published in two papers today in the journal Science. Type I IFN responses are critical for protecting cells and the body from more severe disease after acute viral infection.

Newswise: Talking Alone: Researchers Use Artificial Intelligence Tools to Predict Loneliness
Released: 24-Sep-2020 1:45 PM EDT
Talking Alone: Researchers Use Artificial Intelligence Tools to Predict Loneliness
University of California San Diego Health

A team led by researchers at University of California San Diego School of Medicine has used artificial intelligence technologies to analyze natural language patterns to discern degrees of loneliness in older adults.


Showing results

110 of 3395

close
0.78562